From mammograms to at-home faecal immunochemical tests, eligibility for national screening programmes varies across ages and locations. Ahead of World Cancer Day (February 4), we spoke to Dr Rachel ...

The study, published in the Journal of Gastrointestinal Cancer, evaluated the Rhythm Biosciences (ASX:RHY) first-generation singleplex ColoSTAT test in 989 patients across multiple clinical centres, ...

First peer-reviewed publication validates the first generation ColoSTAT clinical performance with 81.3% sensitivity and 91.% specificity The study, published in the Journal of Gastrointestinal Cancer, ...

Rhythm Biosciences has achieved a major milestone with the peer-reviewed validation of its ColoSTAT blood test, showing strong performance in detecting colorectal cancer. The study, published in the ...

Our pilot program focused on identifying genomic risk of early-onset cancer and heart disease in young adults aged 18-40. The federal government’s introduction of legislation last year to ban genetic ...

The NHS will collect information from patients about 120 different genetic abnormalities to fast-track access to screening.